We just hope this olive branch extended by the pharmaceutical company isn't too little, too late.
From what we know about Josh Hardy though — the kid is a fighter!
Josh was diagnosed with a rare kind of kidney cancer when he was just nine months old, but he eventually beat it. He went on to beat cancer again when it showed up in his thymus, lung, and bone marrow. However, a bone marrow transplant left Josh, now 7-years-old, fighting for his life against a deadly adenovirus.
Since Josh had tried various treatments that didn't work, his family, according to the FDA, was legally allowed to ask pharmaceutical companies for life-saving experimental drugs - which Josh's family did with Chimerix, who initially rejected the family's requests.
However after an online campaign to save Josh Hardy reached over 20,000 followers, the pharmaceutical company has gone ahead and reached a deal with the FDA to begin studying the effects of brincidofovir on the adenovirus, starting with Josh as their first test bunny this Wednesday.
Here's what Chimerix said in a statement:
"Josh Hardy’s story brought to public attention the often-devastating impact of adenovirus infection, and helped accelerate a discussion between the FDA and Chimerix regarding the need for additional clinical development to assess brincidofovir's potential in adenovirus infection. This study is expected to begin with Josh Hardy as the first patient enrolled on Wednesday, March 12."
To which Josh's mother replied to on Facebook with:
"Glory to GOD! They are releasing the drug for Josh!!!!!!!!!"
The company Chimerix has repeatedly alluded to in the past that they don't take part in the compassionate program of providing experimental drugs to families, but obviously they made an exception here with Josh. Hopefully their actions won't be in vain, and Josh will be able to fight against this heartbreaking health issue.
He's done it before, and we believe he can do it again! Go Josh!!!
[Image via Facebook.]